ORIGINAL RESEARCH article
Front. Public Health
Sec. Aging and Public Health
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1551282
This article is part of the Research TopicFrom Vulnerability to Vigor: Innovative Approaches in Frailty and Healthy AgingView all 5 articles
sarcopenia and the frailty progression among Chinese: a longitudinal study
Provisionally accepted
- West China Hospital, Sichuan University, Chengdu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Previous studies primarily focused on baseline sarcopenia status, neglecting changes over time. This study aims to explore the association between changes in sarcopenia status and frailty progression, hypothesizing that transitions to possible sarcopenia or sarcopenia increase frailty risk, while recovery to non-sarcopenia reduces this risk. Methods: Using data from the China Health and Retirement Longitudinal Study (CHARLS), sarcopenia was evaluated at baseline and after two years using the AWGS 2019 criteria. Frailty was assessed with a 32-item frailty index. Cox regression and linear mixed models analyzed the association between sarcopenia transitions and frailty progression. Results: Participants who developed possible sarcopenia or sarcopenia faced a 56% higher frailty risk (HR 1.56, 95% CI 1.21 -2.01) and a faster frailty index increase ( β = 0.007/year, 95% CI 0.005 -0.010) compared to those remaining non-sarcopenic. In contrast, those recovering from sarcopenia to non-sarcopenia or possible sarcopenia had a 46% lower frailty risk (HR 0.54, 95% CI 0.32 -0.89) and a slower frailty index rise ( β = -0.008/year, 95% CI -0.015 to -0.002). Among individuals with possible sarcopenia at baseline, recovery to non-sarcopenia reduced frailty risk by 48% (HR 0.52, 95% CI 0.39-0.68), while progression to sarcopenia increased it by 77% (HR 1.77, 95% CI 1.07-2.94). Conclusions: Transitions in sarcopenia status significantly affect frailty risk and progression. Worsening sarcopenia heightens frailty risk, whereas recovery diminishes it. These findings highlight the value of monitoring and addressing sarcopenia in middle-aged and older adults, offering potential to enhance quality of life and lower healthcare costs through targeted interventions.
Keywords: Sarcopenia, Frailty, Dynamic nature, Epidemiology, CHARLS
Received: 13 Feb 2025; Accepted: 30 Jun 2025.
Copyright: © 2025 Wang, Zeng, Yu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Qingyue Zeng, West China Hospital, Sichuan University, Chengdu, China
Shuangqing Li, West China Hospital, Sichuan University, Chengdu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.